Divi's Laboratories Limited vs Quest Laboratories Limited

A side-by-side comparison of Divi's Laboratories Limited (DIVISLAB) and Quest Laboratories Limited (QUESTLAB) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.

The verdict

On the numbers, Divi's Laboratories Limited leads DIVISLAB vs QUESTLAB on 9 of 14 metrics. See the breakdown below — the right pick still depends on your goals (value vs growth, risk appetite).

  • Valuation22
  • Profitability31
  • Growth02
  • Size & financial health40
ValueReturnsMarginGrowthScaleLow debt

Each axis shows this group's split of that metric, scaled so the leader sits at the edge. Relative to each other, not an absolute score.

Valuation

Even

How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.

94.52
P/E ratio
10.07
14.90
P/B ratio
1.42
0.32%
Dividend yield
0.00%
₹96.75
EPS
₹9.16

Profitability

DIVISLAB takes 3/4

How efficiently each company turns capital and sales into profit. Higher is better.

15.32%
Return on equity
15.51%
20.35%
Return on capital
19.06%
32.59%
EBITDA margin
16.32%
24.32%
Net margin
13.43%

Growth

QUESTLAB takes 2/2

Three-year compounded growth. Faster-growing businesses can justify a higher valuation.

10.78%
Revenue CAGR (3Y)
21.72%
12.09%
Profit CAGR (3Y)
44.29%

Size & financial health

DIVISLAB takes 4/4

Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.

₹2.45L Cr
Market cap
₹151 Cr
₹10,560 Cr
Revenue
₹112 Cr
₹2,568 Cr
Net profit
₹15 Cr
0.00
Debt / equity
0.08
Divi's Laboratories Limited
  • + ["Company has been maintaining a healthy dividend payout of 31.0%", "Company is almost debt free."]
  • − ["Stock is trading at 14.60 times its book value", "The company has delivered a poor sales growth of 8.7% over past five years."]
Quest Laboratories Limited
  • + ["Company has delivered good profit growth of 71.9% CAGR over last 5 years", "Company has a good return on equity (ROE) track record: 3 Years ROE 29.3%", "Company is almost debt free.", "Company has delivered good sales growth of 30.1% CAGR over last 5 years"]
  • − ["Though the company is reporting repeated profits, it is not paying out dividend"]
Divi's Laboratories Limited full analysis Quest Laboratories Limited full analysis

This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.